LEADER 03629nam  2200685Ia 450 
001 9910957298503321
005 20251017110136.0
010   $a9786610180059
010   $a9780309168304
010   $a0309168309
010   $a9781280180057
010   $a1280180056
010   $a9780309507462
010   $a0309507464
035   $a(CKB)111069351131848
035   $a(EBL)3375170
035   $a(SSID)ssj0000236732
035   $a(PQKBManifestationID)11188081
035   $a(PQKBTitleCode)TC0000236732
035   $a(PQKBWorkID)10188775
035   $a(PQKB)10700914
035   $a(MiAaPQ)EBC3375170
035   $a(Au-PeEL)EBL3375170
035   $a(CaPaEBR)ebr10032357
035   $a(OCoLC)923253967
035   $a(Perlego)4733619
035   $a(DNLM)1170171
035   $a(BIP)8465508
035   $a(EXLCZ)99111069351131848
100   $a20030306d2003      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 04$aThe Resistance phenomenon in microbes and infectious disease vectors $eimplications for human health and strategies for containment : workshop summary /$fStacey L. Knobler ... [et al.], editors
205   $a1st ed.
210   $aWashington, D.C. $cNational Academies Press$dc2003
215   $a1 online resource (333 p.)
300   $aDescription based upon print version of record.
311 08$a9780309088541 
311 08$a0309088542 
320   $aIncludes bibliographical references.
327   $a""Front Matter""; ""Reviewers""; ""Preface""; ""Contents""; ""Summary and Assessment""; ""1 Introduction""; ""2 Microbe Resistance""; ""3 Vector Resistance""; ""4 The Economics of Resistance""; ""5 Factors Contributing to the Emergence of Resistance""; ""6 Emerging Tools and Technology for Countering Resistance""; ""7 Strategies to Contain the Development and Consequences of Resistance""; ""Appendix A""; ""Appendix B""; ""Appendix C Information Resources""; ""Appendix D""
327   $a""Appendix E Interventions Against Antimicrobial Resistance: A Review of the Literature and Exploration of Modelling Cost-Effectiveness""""Appendix F A Public Health Action Plan to Combat Antimicrobial Resistance""; ""Appendix G Forum Member, Speaker, and Staff Biographies""
330   $aThe resistance topic is timely given current events. The emergence of mysterious new diseases, such as SARS, and the looming threat of bioterrorist attacks remind us of how vulnerable we can be to infectious agents. With advances in medical technologies, we have tamed many former microbial foes, yet with few new antimicrobial agents and vaccines in the pipeline, and rapidly increasing drug resistance among infectious microbes, we teeter on the brink of loosing the upperhand in our ongoing struggle against these foes, old and new. The Resistance Phenomenon in Microbes and Infectious Disease Vectors examines our understanding of the relationships among microbes, disease vectors, and human hosts, and explores possible new strategies for meeting the challenge of resistance.
606   $aDrug resistance in microorganisms$vCongresses
606   $aMicrobiology
615  0$aDrug resistance in microorganisms
615  0$aMicrobiology.
676   $a616/.01
701   $aKnobler$b Stacey$01804165
712 02$aInstitute of Medicine (U.S.).$bForum on Emerging Infections.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910957298503321
996   $aThe Resistance phenomenon in microbes and infectious disease vectors$94358444
997   $aUNINA